[BLADDER DISEASE DUE TO RADIUM THERAPY. (CLINICAL EXPERIENCES WITH A NEW ANTIBIOTIC-AZO DYE ASSOCIATION, N4,N4'-TEREPHTHALAL-BIS-(D-4-AMINO-3-ISOXAZOLIDONE) AND 2,6 DIAMINO-3-PHENYLAZO-PYRIDINE HYDROCHLORIDE)].
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D001391:Azo Compounds; D004396:Coloring Agents; D006801:Humans; D007555:Isoxazoles; D023303:Oxazolidinones; D011725:Pyridines; D011832:Radiation Injuries; D011883:Radium; D001745:Urinary Bladder Diseases
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D001391:Azo Compounds; D004396:Coloring Agents; D007555:Isoxazoles; D023303:Oxazolidinones; D011725:Pyridines; C013075:3-isoxazolidone; C023666:pyridine; D011883:Radium
ANTIBIOTICS; AZO COMPOUNDS; BLADDER DISEASES; RADIATION INJURY
CISTOPATIA DA RADIUMTERAPIA. (ESPERIENZE CLINICHE CON UNA NUOVA ASSOCIAZIONE ANTIBIOTICO-AZOCOLORANTE(N4,N4'-TEREFTALAL-BIS-(D-4-AMINO-3-ISOXAZOLIDONE)+2,6 DIAMINO-3-FENILAZO-PIRIDINA CLORIDRATO)